Tokunaga Y, Tanaka K, Uemoto S, Sakai Y, Zaima M, Yamaoka Y, Ozawa K
Second Department of Surgery, Faculty of Medicine, Kyoto University, Japan.
J Invest Surg. 1995 Jul-Aug;8(4):243-51. doi: 10.3109/08941939509031598.
Complete hemostasis and proof against bile leakage on the cut surface of the partial liver graft and the remnant liver of the donor are basic desiderata for a successful outcome in living related liver transplantation (LRLT). This study evaluated the efficacy of fibrin glue sealant on the cut surface of a graft in human living related liver transplantation and canine partial liver transplantation in terms of postoperative complications. From June 1990 to August 1993, a series of 70 LRLTs were performed on children with end-stage liver disease. In harvesting the graft from living donor, hepatic parenchyma was transected by ultrasonic aspirator. Clearly exposed vessels were either ligated or suture ligated. Fibrous connecting tissues of the glissonian branches and tiny vessels were coagulated by a newly devised bipolar electric cautery equipped with saline dripping system. Fibrin sealant was sprayed on the cut surface of the liver graft and the remnant liver of the donor. All donors were discharged from hospital at 10 to 17 (mean = 11.6) days after surgery without any complications that required surgical intervention, and were able to return to normal life. At reperfusion of the graft in the recipients, no blood loss from the cut surface was observed. However, bile oozing on the cut surface was observed in 3 of the 70 cases. No infection or foreign body reactions were observed in the fibrin-sealed cut surface of the graft. Actuarial recipient survival rate was 89% (48/54) in elective cases and 69% (11/16) in emergency cases. In canine transplantation, 16 out of 23 beagles survived for 4 days or longer (longest 20 days).(ABSTRACT TRUNCATED AT 250 WORDS)
在活体亲属肝移植(LRLT)中,实现部分肝移植供体的移植肝切面和残余肝脏的完全止血以及防止胆汁渗漏是手术成功的基本要求。本研究从术后并发症方面评估了纤维蛋白胶密封剂在人类活体亲属肝移植和犬部分肝移植的移植肝切面上的疗效。1990年6月至1993年8月,对70例终末期肝病患儿进行了一系列活体亲属肝移植手术。在从活体供体获取移植肝时,用超声吸引器横断肝实质。清晰暴露的血管要么结扎要么缝扎。肝门分支的纤维结缔组织和小血管用新设计的配备生理盐水滴注系统的双极电凝器进行凝固。将纤维蛋白密封剂喷洒在移植肝和供体残余肝脏的切面上。所有供体术后10至17天(平均11.6天)出院,无任何需要手术干预的并发症,且能够恢复正常生活。在受体移植肝再灌注时,未观察到切面出血。然而,70例中有3例观察到切面有胆汁渗出。在纤维蛋白密封的移植肝切面上未观察到感染或异物反应。择期手术病例的受体实际生存率为89%(48/54),急诊病例为69%(11/16)。在犬类移植中,23只比格犬中有16只存活了4天或更长时间(最长20天)。(摘要截选至250词)